偏头痛中的催产素受体对抗性:一个随机,双盲,安慰剂控制的挑研究
Mira Pauline Fitzek1,2, Paula Kleist1, Cleo Handtmann1
1Department of Neurology, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
The journal of headache and pain
|February 17, 2026
概括
催产素受体阻塞并没有在女性或男性中引发偏头痛发作,这表明单独的急性催产素抑制并不是偏头痛的触发因素. 需要对长效抗体进行进一步的研究,才能充分理解催产素在偏头痛中的作用.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 血管生物学 血管生物学
背景情况:
- 催产素参与疼痛调节和血管调节,可能在偏头痛病理生理学中发挥作用.
- 催产素受体在与偏头痛相关的大脑区域和脑血管中发现,与CGRP等调解器相互作用.
- 较低的催产素水平与偏头痛频率的增加相关,但人类的直接因果关系尚未被证明.
研究的目的:
- 调查急性催产素受体阻塞是否会在患有插曲性偏头痛的人中引起偏头痛发作.
- 评估催产素受体对抗作用对偏头痛患者和健康对照者的脑血管功能的影响.
主要方法:
- 一项随机,双盲,安慰剂控制,交叉研究,涉及患有偶发性偏头痛 (WM) 的女性,健康女性 (HC) 和患有偶发性偏头痛 (MM) 的男性.
- 参与者接受了催产素受体对抗剂阿托西班或安慰剂.
- 在妇女中使用持续的荷尔蒙避孕药来稳定荷尔蒙水平;主要终点是WM在12小时内发生类似偏头痛的发作.
主要成果:
- 与安慰剂相比,与阿托西班的急性催产素受体对抗作用并没有显著增加WM中偏头痛类发作的发生率 (30%与20%相比).
- 75%的WM在阿托西班治疗中报告了任何类型的头痛,而在安慰剂治疗中则为55%.
- 健康对照组在使用阿托西班时显示了暂时的血管变化 (动脉直径增加和中脑动脉流速增加),但在偏头痛参与者中没有观察到显著的血管变化.
结论:
- 在稳定的荷尔蒙条件下,短期作用的催产素受体对抗似乎不会引发偏头痛发作.
- 催产素可能在复杂的神经血管网络中起到调节因子的作用,而不是直接引发偏头痛.
- 使用持久较长或穿透大脑的催产素受体抗剂进行进一步的研究是有必要的,以阐明催产素在偏头痛易感性中的确切作用.
相关概念视频
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
719
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
719
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
655
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
655
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
933
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
933
01:26Cholinergic Antagonists: Therapeutic Uses
1.5K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.5K
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.8K
01:28Cholinergic Antagonists: Pharmacological Actions
1.8K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.8K